N-[3-(2-呋喃基)丙烯酰]-L-苯丙氨酰-甘氨酰-甘氨酸(64566-61-6)名称与标识符
名称
中文别名:
N-[3-(2-呋喃基)丙烯酰]-L-苯丙氨酰-甘氨酰-甘氨酸;N-[3-(2-呋喃基)丙烯酰]-L-苯丙氨酰甘氨酰甘氨酸;N-[3-(2-呋喃基)丙烯酰]-L-苯丙氨酰-甘氨酰-甘氨酸FAPGG;N-[1-[N-[1-(N-L-精氨酰甘氨酰)-L-脯氨酰]-L-苯丙氨酰]-L-脯氨酰]-L-异亮氨酸二乙酸盐;
英文别名:
FAPGG;ARG-GLY-PRO-PHE-PRO-ILE;Fa-phe-gly-gly-oh;3-(2-Furylacryloyl)phenylalanyl-glycyl-glycine;ANGIOTENSIN-CONVERTING ENZYME SUBSTRATE;MFCD00036816;CS-W011707;FA-Phe-gly-gly;Glycine, N-[3-(2-furanyl)-1-oxo-2-propenyl]-L-phenylalanylglycyl-;N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly, 99%;(S)-2-(2-(2-(3-(Furan-2-yl)acrylamido)-3-phenylpropanamido)acetamido)acetic acid;AKOS024386390;AS-71985;HY-W010991;Glycine, N-(N-(N-(3-(2-furanyl)-1-oxo-2-propenyl)-L-phenylalanyl)glycyl)-;N-(3-(2-furyl)acryloyl)-L-phenylalanyl-glycyl-glycine;N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly;SCHEMBL1955086;N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly, 97%;64967-39-1;SCHEMBL1957422;BCP09241;2-[[2-[[(2S)-2-[[(E)-3-(furan-2-yl)prop-2-enoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]acetic acid;2-{2-[(2S)-2-[(2E)-3-(furan-2-yl)prop-2-enamido]-3-phenylpropanamido]acetamido}acetic acid;64566-61-6;H11493;N-[3-(2-Furyl)acryloyl]-L-phenylalanyl-glycyl-glycine;
标识符
InChIKey:
ZDLZKMDMBBMJLI-FDMDGMSGSA-N
Inchi:
1S/C20H21N3O6/c24-17(9-8-15-7-4-10-29-15)23-16(11-14-5-2-1-3-6-14)20(28)22-12-18(25)21-13-19(26)27/h1-10,16H,11-13H2,(H,21,25)(H,22,28)(H,23,24)(H,26,27)/b9-8+/t16-/m0/s1
SMILES:
O=C([C@H](CC1C=CC=CC=1)NC(/C=C/C1=CC=CO1)=O)NCC(NCC(=O)O)=O